中药企业迎来国资整合潮

药智网
Aug 08

市值TOP10的中药企业中,拥有国资背景的已占80%。01中药行业国资整合提速优势互补重塑格局根据同花顺财经数据,截至8月6日,A股中药板块共有约69家上市公司。进一步梳理发现,其中具备国资背景的企业约20家,占比约29%。从头部企业来看,在市值排名前十的中药企业中,80%为国资背景,具体包括片仔癀、云南白药、华润三九、同仁堂、白云山、东阿阿胶、达仁堂及康美药业。在医药行业并购重组的浪潮中,中药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10